Diasorin SpA buy melinda
Start price
12.10.18
/
50%
€80.80
Target price
21.01.19
€93.70
Performance (%)
-1.92%
End price
21.01.19
€79.25
Summary
This prediction ended on 21.01.19 with a price of €79.25. With a performance of -1.92%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Diasorin SpA | 6.943% | 6.943% | -6.604% | -26.405% |
| iShares Core DAX® | 4.094% | 4.888% | 17.421% | 22.413% |
| iShares Nasdaq 100 | 1.424% | -0.445% | 37.618% | 58.203% |
| iShares Nikkei 225® | -1.572% | -4.911% | 12.951% | 7.961% |
| iShares S&P 500 | 1.822% | 0.776% | 29.182% | 49.914% |
According to melinda what are the pros and cons of Diasorin SpA for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Diasorin SpA diskutieren
SecteurEquipement, fournitures et distribution médicale Agenda 07/11 Publication de résultats
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.
It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology.
The company was founded in 1968 and is headquartered in Vercelli, Italy
(Vom Mitglied beendet)
Stopped prediction by melinda for Diasorin SpA
Diasorin SpA
Start price
Target price
Perf. (%)
€142.25
06.06.21
06.06.21
-
06.06.22
06.06.22
-15.04%
07.06.22
07.06.22
Could be worthwhile Investment >10% per year
Diasorin SpA
Start price
Target price
Perf. (%)
€91.15
07.04.19
07.04.19
€96.00
16.05.19
16.05.19
7.02%
16.05.19
16.05.19
Could be worthwhile Investment >10% per year